Top Emerging Trends

Recent Posts

FDA Advisory Committee Votes to Recommend Keeping Anti-Diabetes Drug Avandia On The Market
Posted on 18 Jul 2010 by Tom Moylan

GAITHERSBURG, Md. - (Mealey's) A majority of Food and Drug Administration advisers voted July 14 to keep Avandia on the market but split on whether the anti-diabetes drug made by GlaxoSmithKline PLC (GSK) should carry additional warnings about its... Read More

Plaintiff Expert Excluded by Eleventh Circuit in First Seroquel MDL Bellwether
Posted on 8 Apr 2010 by Tom Moylan

ATLANTA - (Mealey's) The sole causation expert for the first bellwether plaintiff in the Seroquel multidistrict litigation failed to rule out other causes of weight gain and diabetes, a panel of the 11th Circuit U.S. Court of Appeals said April 7... Read More